Wenduo Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wenduo Cheng has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Anna Hupalowska
Genentech, USA
1 shared publication - Aviv Regev
Department of Biology, Massachusetts Institute of Technology, Cambridge, USA
1 shared publication - Christine Bakan
Genentech, USA
1 shared publication - Gaurav Agrawal
Medra AI, USA
1 shared publication - Jennifer E. Rood
Genentech, USA
1 shared publication - Jian Ma
Ray and Stephanie Lane Computational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, PA, USA
1 shared publication
Latest Publications
- Open Access
- 5 August 2026
- Published by MDPI AG in Preprints.org
Towards Human-Led, Agent-Driven Autonomous Laboratories for the Life Sciences
Large language model (LLM)-based agents can increasingly support and empower human scientists in their work by reading literature, generating hypotheses, designing experiments, analyzing data, interpreting results, and drafting manuscripts. In parallel, robotics and programmable, cloud-connected laboratories have the potential to transform wet-lab operations into software-addressable infrastructure. Yet biological experiments face a persistent reality gap in which silent failures, temporal drift, contamination, sample mix-ups, and ambiguous protocol intent can invalidate an otherwise sound experimental plan. Closing this gap is essential for bringing the speed of modern computational discovery to experimental biology and requires audit-grade execution and verification. Here, we distinguish scripted automation from flexible, AI-enabled autonomy and outline a staged roadmap toward human-led and trustworthy “self-driving” labs for biology. We define laboratory autonomy in the context of a human-led scientific endeavor as a bounded control loop in which scientists set goals and constraints, agents help plan and coordinate experiments, instruments execute experiments and report machine-checkable evidence, and humans verify and interpret results and govern high-consequence decisions. We discuss where such systems are most appropriate and relevant today and where caution or deferral is needed. We map key lab-side potential failure modes and argue for verifiability-first autonomy. If developed responsibly, such systems could enable scientists to more efficiently decipher combinatorially large perturbation, design, and optimization spaces that are currently impractical to test experimentally, while empowering, rather than replacing, human creativity and judgment in experimental biological discovery.
- 5 August 2026
- Published by MDPI AG in Preprints.org
Open AccessTowards Human-Led, Agent-Driven Autonomous Laboratories for the Life Sciences
Large language model (LLM)-based agents can increasingly support and empower human scientists in their work by reading literature, generating hypotheses, designing experiments, analyzing data, interpreting results, and drafting manuscripts. In parallel, robotics and programmable, cloud-connected laboratories have the potential to transform wet-lab operations into software-addressable infrastructure. Yet biological experiments face a persistent reality gap in which silent failures, temporal drift, contamination, sample mix-ups, and ambiguous protocol intent can invalidate an otherwise sound experimental plan. Closing this gap is essential for bringing the speed of modern computational discovery to experimental biology and requires audit-grade execution and verification. Here, we distinguish scripted automation from flexible, AI-enabled autonomy and outline a staged roadmap toward human-led and trustworthy “self-driving” labs for biology. We define laboratory autonomy in the context of a human-led scientific endeavor as a bounded control loop in which scientists set goals and constraints, agents help plan and coordinate experiments, instruments execute experiments and report machine-checkable evidence, and humans verify and interpret results and govern high-consequence decisions. We discuss where such systems are most appropriate and relevant today and where caution or deferral is needed. We map key lab-side potential failure modes and argue for verifiability-first autonomy. If developed responsibly, such systems could enable scientists to more efficiently decipher combinatorially large perturbation, design, and optimization spaces that are currently impractical to test experimentally, while empowering, rather than replacing, human creativity and judgment in experimental biological discovery.